Search results
Novavax shares skyrocket after billion-dollar licensing deal with Sanofi By Proactive Investors
Investing.com· 9 hours agoThe deal encompasses the commercialization of a combined COVID-19 and flu shot, marking a pivotal...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 19 hours ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 9 hours agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 8 hours agoCovid-19 vaccine. The agreement will also provide Sanofi with a sole license to the vaccine for use...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 15 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
France's Sanofi in COVID-19 vaccine deal with Novavax - statement
Reuters via Yahoo Finance· 19 hours ago"We're excited by the prospect of combining Novavax's adjuvanted COVID-19 vaccine that has shown high efficacy and ...
Novavax’s 99% Surge Gives ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg via Yahoo Finance· 5 hours ago(Bloomberg) -- Novavax Inc.’s record one-day gain is forcing some short sellers betting against the...
Novavax stock soars 120% as Sanofi deal 'kicks off a new chapter' By Investing.com
Investing.com· 17 hours agoDespite missing Q1 estimates, NVAX stock rose sharply after the company announced it has secured a...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 9 hours agoNovavax will receive as much as $1.2 billion as part of a Covid vaccine licensing deal with Sanofi.
French, US Drug Firms Team Up For Covid-flu Shot
International Business Times· 14 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax's Covid-19 vaccine worldwide ...